Literature DB >> 17122512

Intraductal papillary mucinous neoplasm (IPMN) of the pancreas: its histopathologic difference between 2 major types.

Shinichi Ban1, Yoshihisa Naitoh, Mari Mino-Kenudson, Takaki Sakurai, Makoto Kuroda, Isamu Koyama, Gregory Y Lauwers, Michio Shimizu.   

Abstract

Intraductal papillary mucinous neoplasm (IPMN) is a unique pancreatic neoplasm developing in the ductal system. Two major histologic subtypes have been reported, that is the gastric type and the intestinal type. However, their histopathologic features, especially those of the gastric type, have not been fully described. To evaluate the features of these two types and refine their differences, we analyzed 80 IPMNs including 50 cases of the gastric type and 30 cases of the intestinal type with mucin immunohistochemistry. By defining a main duct-type lesion as predominantly involving the main pancreatic duct with or without branch ducts, and a branch duct-type lesion as exclusively centered on branch ducts or consisting of a collection of small cystic lesions, gastric-type IPMNs were mostly branch duct-type lesions (98%), whereas the intestinal-type IPMNs were usually main duct type (73%). The histologic grade of the intestinal type was generally higher than that of the gastric type. The intestinal type was also characterized by frequent intraluminal nodular growth, and severe atrophy and fibrosis of the surrounding parenchyma with mucous lake formation. In contrast, pyloric glandlike structures at the base of the papillae and pancreatic intraepithelial neoplasia (PanIN)-like complexes were more frequently observed in the gastric type. A significant difference was observed between the gastric type and the intestinal type with regard to all the above features (P<0.05). Seven cases (23%) of the intestinal type were associated with an invasive adenocarcinoma (6 mucinous and 1 ductal), versus only 1 case (2%) of the gastric type (invasive ductal carcinoma). All cases of both gastric and intestinal types expressed MUC5AC; however, high immunolabeling scores for MUC2 were mostly observed in the intestinal type (P<0.05). In conclusion, gastric and intestinal types of IPMNs have distinct histopathologic features and mucin profiles, suggesting that they may follow different biologic pathways.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17122512     DOI: 10.1097/01.pas.0000213305.98187.d4

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  50 in total

1.  Claudin-18 is an early-stage marker of pancreatic carcinogenesis.

Authors:  Mariko Tanaka; Junji Shibahara; Noriyoshi Fukushima; Aya Shinozaki; Makoto Umeda; Shumpei Ishikawa; Norihiro Kokudo; Masashi Fukayama
Journal:  J Histochem Cytochem       Date:  2011-08-10       Impact factor: 2.479

Review 2.  IPMN: surgical treatment.

Authors:  Reto M Käppeli; Sascha A Müller; Bianka Hummel; Christina Kruse; Philip Müller; Jürgen Fornaro; Alexander Wilhelm; Marcel Zadnikar; Bruno M Schmied; Ignazio Tarantino
Journal:  Langenbecks Arch Surg       Date:  2013-09-03       Impact factor: 3.445

Review 3.  [Intraductal papillary mucinous neoplasia: which findings support observation?].

Authors:  J Mayerle; M Kraft; P Menges; P Simon; J Ringel; L I Partecke; C D Heidecke; M M Lerch
Journal:  Chirurg       Date:  2012-02       Impact factor: 0.955

4.  Multicentric invasive carcinomas derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas: report of a case.

Authors:  Yoshihisa Naitoh; Shinichi Ban; Chouji Tsuchiya; Yoshiaki Sugiura; Michio Shimizu
Journal:  Virchows Arch       Date:  2007-02-28       Impact factor: 4.064

5.  A new approach to managing intraductal papillary mucinous pancreatic neoplasms.

Authors:  Paula Ghaneh; John Neoptolemos
Journal:  Gut       Date:  2007-08       Impact factor: 23.059

6.  Pathologic Evaluation and Reporting of Intraductal Papillary Mucinous Neoplasms of the Pancreas and Other Tumoral Intraepithelial Neoplasms of Pancreatobiliary Tract: Recommendations of Verona Consensus Meeting.

Authors:  Volkan Adsay; Mari Mino-Kenudson; Toru Furukawa; Olca Basturk; Giuseppe Zamboni; Giovanni Marchegiani; Claudio Bassi; Roberto Salvia; Giuseppe Malleo; Salvatore Paiella; Christopher L Wolfgang; Hanno Matthaei; G Johan Offerhaus; Mustapha Adham; Marco J Bruno; Michelle D Reid; Alyssa Krasinskas; Günter Klöppel; Nobuyuki Ohike; Takuma Tajiri; Kee-Taek Jang; Juan Carlos Roa; Peter Allen; Carlos Fernández-del Castillo; Jin-Young Jang; David S Klimstra; Ralph H Hruban
Journal:  Ann Surg       Date:  2016-01       Impact factor: 12.969

Review 7.  Precursors to pancreatic cancer.

Authors:  Ralph H Hruban; Anirban Maitra; Scott E Kern; Michael Goggins
Journal:  Gastroenterol Clin North Am       Date:  2007-12       Impact factor: 3.806

8.  Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.

Authors:  Junpei Yamaguchi; Mari Mino-Kenudson; Andrew S Liss; Sanjib Chowdhury; Timothy C Wang; Carlos Fernández-Del Castillo; Keith D Lillemoe; Andrew L Warshaw; Sarah P Thayer
Journal:  Gastroenterology       Date:  2016-08-12       Impact factor: 22.682

Review 9.  Early detection of pancreatic cancer using DNA-based molecular approaches.

Authors:  Aatur D Singhi; Laura D Wood
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-06-07       Impact factor: 46.802

10.  A Case Report of Intraductal Papillary-Mucinous Neoplasm of the Pancreas Showing Morphologic Transformation during Followup Periods.

Authors:  Yuichi Sanada; Shinji Osada; Yoshihiro Tanaka; Yasuharu Tokuyama; Kazuhiro Yoshida
Journal:  J Oncol       Date:  2009-10-15       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.